{"id":"investigational-drug","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL157030","moleculeType":"Small molecule","molecularWeight":"883.99"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"This entry refers to an investigational drug from Pfizer in Phase 3 development, but without a specific drug name, brand name, or development code, the molecular mechanism cannot be accurately identified. Additional identifying information is required to characterize the drug's mechanism of action.","oneSentence":"Unable to determine specific mechanism without drug name or code identifier.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:16:53.243Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT07498595","phase":"EARLY_PHASE1","title":"TILs Plus Third-Generation EGFR-TKI Therapy for TKI-Resistant NSCLC","status":"NOT_YET_RECRUITING","sponsor":"Tianjin Medical University General Hospital","startDate":"2026-03-31","conditions":"EGFR-TKI-resistant Non-Small Cell Lung Cancer","enrollment":50},{"nctId":"NCT07498647","phase":"PHASE2","title":"Clinical Trial of BR2251 Tablets for Patients With Primary Gout and Hyperuricemia","status":"NOT_YET_RECRUITING","sponsor":"BioRay Pharmaceutical Co., Ltd.","startDate":"2026-04-01","conditions":"Gout and Hyperuricemia","enrollment":160},{"nctId":"NCT06453668","phase":"PHASE1","title":"A Study of TCD601 (Siplizumab) in Newly Diagnosed Adult Amyotrophic Lateral Sclerosis (ALS) Patients","status":"RECRUITING","sponsor":"ITB-Med LLC","startDate":"2024-04-16","conditions":"ALS","enrollment":48},{"nctId":"NCT07427680","phase":"PHASE1, PHASE2","title":"Study of TGM-312-SC01 in Healthy Participants and Adults With MASH","status":"RECRUITING","sponsor":"Tangram Therapeutics Plc","startDate":"2026-02","conditions":"Healthy Participants, MASH - Metabolic Dysfunction-Associated Steatohepatitis","enrollment":99},{"nctId":"NCT06166849","phase":"NA","title":"Clinical Evaluation of an Experimental Remineralization Product","status":"COMPLETED","sponsor":"Ivoclar Vivadent AG","startDate":"2023-03-28","conditions":"White Spot Lesion","enrollment":43},{"nctId":"NCT04316546","phase":"PHASE2","title":"MK-7075 (Miransertib) in Proteus Syndrome","status":"RECRUITING","sponsor":"National Human Genome Research Institute (NHGRI)","startDate":"2022-05-20","conditions":"Proteus Syndrome","enrollment":45},{"nctId":"NCT07463807","phase":"PHASE1, PHASE2","title":"Testing the Investigational Medication Combination of Teclistamab and Pomalidomide Compared to the Usual Treatment (Carfilzomib, Pomalidomide, and Dexamethasone) for Patients With Multiple Myeloma Who Have Relapsed Shortly After Treatment","status":"NOT_YET_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2026-06-26","conditions":"Recurrent Multiple Myeloma, Refractory Multiple Myeloma","enrollment":162},{"nctId":"NCT05652504","phase":"PHASE1","title":"Safety Evaluation of PfSPZ Vaccine in Pregnant Women in Mali (MalVIP1)","status":"SUSPENDED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2026-04-01","conditions":"Malaria","enrollment":400},{"nctId":"NCT07371650","phase":"PHASE2","title":"This is an Early-stage Clinical Trial to Determine a Safe and Effective Dose for Tivoxavir Marboxil in Patients With Mild to Moderate Influenza","status":"ACTIVE_NOT_RECRUITING","sponsor":"Traws Pharma, Inc.","startDate":"2025-12-15","conditions":"Influenza","enrollment":105},{"nctId":"NCT07309393","phase":"NA","title":"Impact of Sugammadex Versus Neostigmine on Early Postoperative Pulmonary Function","status":"RECRUITING","sponsor":"Shanghai Pulmonary Hospital, Shanghai, China","startDate":"2025-12-31","conditions":"Residual Neuromuscular Block","enrollment":240},{"nctId":"NCT06564818","phase":"PHASE3","title":"\"A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder\"","status":"RECRUITING","sponsor":"Cybin IRL Limited","startDate":"2024-12-17","conditions":"Major Depressive Disorder","enrollment":220},{"nctId":"NCT07498218","phase":"PHASE1","title":"Phase 1 Study of VELGRAFT, a Living Cellular Construct, in the Management of Chronic Diabetic Foot Ulcers Which Have Attained Granulation Tissue","status":"NOT_YET_RECRUITING","sponsor":"Ayu, Inc.","startDate":"2026-03-02","conditions":"Diabetic Foot Ulcer (DFU), Granulation of Chronic Diabetic Wounds","enrollment":24},{"nctId":"NCT06557733","phase":"PHASE2","title":"An Investigational Drug (TPST-1495) in Patients With Familial Adenomatous Polyposis","status":"NOT_YET_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2026-08-22","conditions":"Colorectal Carcinoma, Familial Adenomatous Polyposis","enrollment":38},{"nctId":"NCT06299319","phase":"PHASE1","title":"Feasibility, Clinical Effects, and Safety of Psilocybin-assisted Psychotherapy for Treatment-resistant OCD","status":"RECRUITING","sponsor":"Centre for Addiction and Mental Health","startDate":"2024-09-01","conditions":"Obsessive-Compulsive Disorder","enrollment":10},{"nctId":"NCT06678074","phase":"PHASE1, PHASE2","title":"Pilot Study of IC14 (Atibuclimab), an Anti-CD14 Monoclonal Antibody, to Treat STEMI","status":"ACTIVE_NOT_RECRUITING","sponsor":"Implicit Bioscience","startDate":"2025-02-06","conditions":"STEMI, STEMI (ST Elevation MI), STEMI - ST Elevation Myocardial Infarction (MI)","enrollment":10},{"nctId":"NCT04281290","phase":"NA","title":"Electrochemotherapy of Posterior Resection Surface for Lowering Disease Recurrence Rate in Pancreatic Cancer (PanECT Study)","status":"ACTIVE_NOT_RECRUITING","sponsor":"University Medical Centre Ljubljana","startDate":"2020-07-13","conditions":"Pancreas Cancer","enrollment":10},{"nctId":"NCT07244991","phase":"NA","title":"Effect of MI Paste Plus™ on Streptococcus Mutans and White Spot Lesions in Fixed Orthodontics","status":"RECRUITING","sponsor":"Cardenal Herrera University","startDate":"2026-01-04","conditions":"Dental Caries, Streptococcus Mutans, Tooth Demineralization","enrollment":200},{"nctId":"NCT06948084","phase":"PHASE2","title":"Testing the Investigational Medication Combination of Daratumumab and Teclistamab Compared to the Usual Treatment (Daratumumab, Pomalidomide, Dexamethasone or Daratumumab, Carfilzomib, Dexamethasone) for Patients With High-risk Multiple Myeloma Refractory or in First Relapse","status":"NOT_YET_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2026-04-29","conditions":"Recurrent Multiple Myeloma, Refractory Multiple Myeloma","enrollment":80},{"nctId":"NCT05165810","phase":"NA","title":"Evaluation of Multiple Interventions to Improve HIV Treatment Outcomes Among People Who Inject Drugs in India","status":"ACTIVE_NOT_RECRUITING","sponsor":"Johns Hopkins University","startDate":"2023-03-09","conditions":"HIV Infections","enrollment":800},{"nctId":"NCT07496164","phase":"NA","title":"A Clinical Study Assessing the Maximum Maxillary Bite Force When Using Three Denture Adhesives Compared to Using No-Adhesive","status":"NOT_YET_RECRUITING","sponsor":"HALEON","startDate":"2026-03","conditions":"Denture Retention","enrollment":60},{"nctId":"NCT06726148","phase":"PHASE1, PHASE2","title":"Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and Other Advanced Solid Tumors","status":"RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2025-04-03","conditions":"Advanced HR+/HER2- Breast Cancer, Advanced CCNE1-amplified Solid Tumors","enrollment":280},{"nctId":"NCT03436654","phase":"PHASE2","title":"Multi-arm Multi-modality Therapy for Very High Risk Localized and Low Volume Metastatic Prostatic Adenocarcinoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2018-06-21","conditions":"Prostate Cancer","enrollment":102},{"nctId":"NCT06843447","phase":"PHASE1, PHASE2","title":"A Clinical Study of Raludotatug Deruxtecan in People With Ovarian Cancer (MK-5909-003)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2025-04-15","conditions":"Ovarian Cancer Recurrent","enrollment":280},{"nctId":"NCT03410992","phase":"PHASE3","title":"A Study With a Initial Treatment Period Followed by a Randomized-withdrawal Period to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis","status":"COMPLETED","sponsor":"UCB Biopharma SRL","startDate":"2018-02-05","conditions":"Chronic Plaque Psoriasis, Moderate to Severe Chronic Plaque Psoriasis, Psoriatic Arthritis","enrollment":435},{"nctId":"NCT07498439","phase":"EARLY_PHASE1","title":"TILs Therapy for Multiple Primary Early-Stage NSCLC","status":"NOT_YET_RECRUITING","sponsor":"Tianjin Medical University General Hospital","startDate":"2026-03-31","conditions":"Primary Early-stage Non-small Cell Lung Cancer","enrollment":50},{"nctId":"NCT02543983","phase":"PHASE2","title":"Neurobiology of Suicide","status":"RECRUITING","sponsor":"National Institute of Mental Health (NIMH)","startDate":"2015-12-01","conditions":"Healthy Volunteers, Depression","enrollment":325},{"nctId":"NCT02639299","phase":"","title":"Screening of Healthy Volunteers for Investigational Antimalarial Drugs, Malaria Vaccines, and Controlled Human Malaria Challenge","status":"RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2016-12-08","conditions":"Malaria","enrollment":1500},{"nctId":"NCT07498673","phase":"EARLY_PHASE1","title":"A Study of YKST02 in Participants With Primary IgA Nephropathy","status":"NOT_YET_RECRUITING","sponsor":"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","startDate":"2026-03-31","conditions":"Primary IgA Nephropathy","enrollment":12},{"nctId":"NCT00931463","phase":"PHASE4","title":"A Trial of 2 Options for Second Line Combination Antiretroviral Therapy Following Virological Failure of a Standard Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI)+2N(t)RTI First Line Regimen","status":"COMPLETED","sponsor":"Kirby Institute","startDate":"2009-09","conditions":"HIV Infections","enrollment":558},{"nctId":"NCT06544694","phase":"PHASE3","title":"A Study to Investigate the Effect of 0.003% AR-15512 on Subjects With Dry Eye Disease","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2024-10-08","conditions":"Dry Eye Disease","enrollment":80},{"nctId":"NCT05063552","phase":"PHASE2, PHASE3","title":"Testing the Use of Investigational Drugs Atezolizumab and/or Bevacizumab With or Without Standard Chemotherapy in the Second-Line Treatment of Advanced-Stage Head and Neck Cancers","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2023-03-13","conditions":"Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Metastatic Head and Neck Squamous Cell Carcinoma, Metastatic Hypopharyngeal Squamous Cell Carcinoma","enrollment":430},{"nctId":"NCT07496619","phase":"NA","title":"Effects of Diabetic Educational Intervention and Dietary Supplements on Blood Glucose, Lipid Profile Levels, Body Mass Index, and Pain Management Among Adult Individuals With Painful Diabetic Peripheral Neuropathy.","status":"COMPLETED","sponsor":"Al-Quds University","startDate":"2022-03-01","conditions":"Pain, Glucose Levels, Low-density Lipoprotein Lipid Composition","enrollment":62},{"nctId":"NCT06565988","phase":"NA","title":"A Post-market-clinical Follow-up Investigation of Safety and Performance by Decoria® Voluma","status":"COMPLETED","sponsor":"Bohus Biotech AB","startDate":"2024-09-02","conditions":"Midface Volume Deficit","enrollment":111},{"nctId":"NCT07492771","phase":"PHASE1","title":"MP101 in Adults With Acute Pseudomonas Aeruginosa Pneumonia","status":"NOT_YET_RECRUITING","sponsor":"MicrobiotiX Co., Ltd","startDate":"2026-03","conditions":"Pneumonia - Bacterial, Pseudomonas Aeruginosa Infection","enrollment":18},{"nctId":"NCT07474402","phase":"NA","title":"The Effect of a Multi-Component Breastfeeding Support Program on Breastfeeding Self-Efficacy and Mother-Infant Bonding in Mothers Following Cesarean Section","status":"RECRUITING","sponsor":"Cumhuriyet University","startDate":"2026-02-20","conditions":"Breastfeeding Self-Efficacy, Mother-Infant Attachment, Breastfeeding Consultancy Training","enrollment":100},{"nctId":"NCT07316166","phase":"PHASE4","title":"Suprainguinal Fascia Iliaca Block With vs Without Dexmedetomidine","status":"RECRUITING","sponsor":"Rhode Island Hospital","startDate":"2026-01-20","conditions":"Postoperative Pain Management","enrollment":120},{"nctId":"NCT07407140","phase":"PHASE3","title":"VAG Versus Standard Chemotherapy With FLT3 Inhibitor in Adult Patients With FLT3-Mutated AML","status":"NOT_YET_RECRUITING","sponsor":"Institute of Hematology & Blood Diseases Hospital, China","startDate":"2026-04-30","conditions":"AML, Adult","enrollment":300},{"nctId":"NCT06854393","phase":"PHASE2","title":"Lacripep for Corneal Wound Healing Study","status":"RECRUITING","sponsor":"Henry M. Jackson Foundation for the Advancement of Military Medicine","startDate":"2025-05-23","conditions":"Corneal Epithelial Wound Healing","enrollment":88},{"nctId":"NCT06232044","phase":"PHASE1, PHASE2","title":"Testing the Combination of Two Approved Drugs and One Experimental Drug in Patients With Relapsed or Refractory Multiple Myeloma","status":"RECRUITING","sponsor":"Alliance for Clinical Trials in Oncology","startDate":"2025-04-23","conditions":"Recurrent Multiple Myeloma, Refractory Multiple Myeloma","enrollment":88},{"nctId":"NCT07371338","phase":"PHASE1","title":"Phase 1 Clinical Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of IPS101A in Parkinson's Disease Patients","status":"RECRUITING","sponsor":"Innopeutics Corporation","startDate":"2026-05-30","conditions":"Parkinson Disease, Parkinson's Disease","enrollment":6},{"nctId":"NCT07493070","phase":"NA","title":"Ultra-stable Iodized Oil-Chemo Embolization Seq Thermal Ablation in Early Liver Ca","status":"ACTIVE_NOT_RECRUITING","sponsor":"Fujian Medical University Union Hospital","startDate":"2026-02-10","conditions":"Hepatocellular Carcinoma (HCC)","enrollment":30},{"nctId":"NCT07138755","phase":"PHASE2","title":"The Efficacy and Safety of the Combination of PD-1 With Chemotherapy and Adaptive Radiotherapy Strategy in the Treatment of Stage III Non-small Cell Lung Cancer Patients","status":"RECRUITING","sponsor":"The Third Xiangya Hospital of Central South University","startDate":"2025-08-29","conditions":"NSCLC, Sintilimab, Adaptive Radiotherapy","enrollment":35},{"nctId":"NCT05321121","phase":"PHASE4","title":"Dexmedotomidine for Acute Pain Control in Patients With Multiple Rib FracturesRandomized Controlled Trial","status":"COMPLETED","sponsor":"University of California, Irvine","startDate":"2021-11-12","conditions":"Rib Fractures, Pain, Acute","enrollment":41},{"nctId":"NCT06265688","phase":"PHASE1","title":"First In Human Study of CX-2051 in Advanced Solid Tumors","status":"RECRUITING","sponsor":"CytomX Therapeutics","startDate":"2024-04-02","conditions":"Solid Tumor, Adult","enrollment":160},{"nctId":"NCT07488611","phase":"PHASE3","title":"PROGAIN Trial in Gastric Cancer Surgery","status":"RECRUITING","sponsor":"Soonchunhyang University Hospital","startDate":"2026-02-13","conditions":"Stomach (Gastric) Cancer","enrollment":100},{"nctId":"NCT07492069","phase":"NA","title":"Life Skills-Based Intervention on Substance Use Intention in Adolescents in Social Care Institutions","status":"NOT_YET_RECRUITING","sponsor":"Universidad Autonoma de Baja California","startDate":"2026-08-30","conditions":"Institutionalization","enrollment":20},{"nctId":"NCT07485764","phase":"PHASE4","title":"Metformin Combined With Secukinumab for Moderate-to-Severe Plaque Psoriasis in Overweight or Obese Chinese Patients","status":"NOT_YET_RECRUITING","sponsor":"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","startDate":"2026-06","conditions":"Psoriasis, Plaque Psoriasis, Moderate-to-severe Plaque Psoriasis","enrollment":186},{"nctId":"NCT06798623","phase":"PHASE1","title":"Anterior Cruciate Ligament (ACL) Reconstruction With Autologous Fat Pad Derived Mesenchymal Stem Cells","status":"RECRUITING","sponsor":"The Methodist Hospital Research Institute","startDate":"2026-03-24","conditions":"Anterior Cruciate Ligament Reconstruction","enrollment":15},{"nctId":"NCT07093398","phase":"PHASE1","title":"A Phase 1 Study to Assess Food Effect on the Pharmacokinetics of D3S-001 in Healthy Adult Participants","status":"COMPLETED","sponsor":"D3 Bio (Wuxi) Co., Ltd","startDate":"2025-07-11","conditions":"Healthy Adult Volunteers","enrollment":26},{"nctId":"NCT07493421","phase":"NA","title":"To Evaluate the Feasibility and Safety of Combining Surgery (Pancreatectomy and Cytoreduction) With HIPEC for Treating Pancreatic Cancer With Peritoneal Involvement.","status":"RECRUITING","sponsor":"Unidade Local de Saúde São João","startDate":"2026-03-01","conditions":"Pancreatic Adenocarcinoma, Peritoneal (Metastatic) Cancer","enrollment":20},{"nctId":"NCT07492017","phase":"NA","title":"The Effect of Puzzles on Nursing Students' Learning to Intramuscular Injection: A Randomized Controlled Study","status":"COMPLETED","sponsor":"Trakya University","startDate":"2025-02-09","conditions":"Learning Concepts and Skills","enrollment":140},{"nctId":"NCT07339774","phase":"PHASE2","title":"Traditional Chinese Medicine Preparation Alleviates Radiotherapy-induced Oral Mucositis in Head and Neck Cancer Patients.","status":"RECRUITING","sponsor":"West China Hospital","startDate":"2026-03-30","conditions":"Radiotherapy-induced Oral Mucositis","enrollment":128},{"nctId":"NCT07493395","phase":"PHASE2","title":"Phase IIa Trial of Anti-CD19 CAR T-Cells in Systemic Sclerosis Resistant to Immunosuppressive Therapy","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Montpellier","startDate":"2026-04-01","conditions":"Scleroderma, Systemic","enrollment":6},{"nctId":"NCT05395741","phase":"PHASE1, PHASE2","title":"Regorafenib in Patients With Refractory Primary Bone Tumors","status":"ACTIVE_NOT_RECRUITING","sponsor":"Institute of Mother and Child, Warsaw, Poland","startDate":"2022-04-28","conditions":"Osteosarcoma, Ewing Sarcoma of Bone","enrollment":30},{"nctId":"NCT07042373","phase":"NA","title":"Effects of Tobacco Abuse Liability-dependent Taxes in the ETM","status":"NOT_YET_RECRUITING","sponsor":"Virginia Polytechnic Institute and State University","startDate":"2026-07-31","conditions":"Cigarette Smoking Behavior","enrollment":51},{"nctId":"NCT07395986","phase":"PHASE2","title":"A Multicenter, Randomized, Double-Masked, Placebo-Controlled Pilot Study to Evaluate the Efficacy and Safety of ZOC2017217 in Subjects With Age-Related Cataract","status":"ENROLLING_BY_INVITATION","sponsor":"Ocusun Ophthalmic Pharmaceutical (Guangzhou) Co., Ltd.","startDate":"2026-02-10","conditions":"Age Related Cataracts","enrollment":40},{"nctId":"NCT07491796","phase":"NA","title":"Comparison of One-Step and Two-Step Light Curing of Bonding Agents and Composite in Orthodontics","status":"COMPLETED","sponsor":"Shaheed Zulfiqar Ali Bhutto Medical University","startDate":"2022-05-04","conditions":"Orthodontic Treatment, Bracket Failure","enrollment":64},{"nctId":"NCT07174947","phase":"PHASE2","title":"SSRI Antidepressant Fluoxetine Improving Immunotherapy Efficacy in Advanced Hepatobiliary Malignancy Patients With Depression and Anxiety","status":"RECRUITING","sponsor":"First Affiliated Hospital of Wenzhou Medical University","startDate":"2025-10-01","conditions":"Hepatobiliary Malignancy, Fluoxetine, Anxiety Disorders","enrollment":240},{"nctId":"NCT07330258","phase":"","title":"A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications","status":"RECRUITING","sponsor":"Bayer","startDate":"2026-03-31","conditions":"Parkinson's Disease","enrollment":300},{"nctId":"NCT07490275","phase":"PHASE1","title":"Allogeneic CD19/BCMA-Targeted CAR-γδT Cell Therapy: Safety and Preliminary Pharmacodynamics in Relapsed/Refractory Autoimmune Diseases","status":"NOT_YET_RECRUITING","sponsor":"Institute of Hematology & Blood Diseases Hospital, China","startDate":"2026-03-01","conditions":"Refractory/Relapsed Systemic Lupus Erythematosus, Refractory / Relapsed / Progressive Systemic Sclerosis, Refractory / Relapsing / Progressive Inflammatory Myopathy","enrollment":9},{"nctId":"NCT07491263","phase":"PHASE1","title":"Clinical Study of Universal CD19 CAR-γδ T Cell Infusion in the Treatment of Relapsed/Refractory Acute B Lymphoblastic Leukemia","status":"NOT_YET_RECRUITING","sponsor":"Fujian Medical University","startDate":"2026-05-01","conditions":"Relapsed/Refractory CD19-positive B-ALL","enrollment":6},{"nctId":"NCT06925321","phase":"PHASE3","title":"A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Patients With Invasive Mold Infections.","status":"RECRUITING","sponsor":"Basilea Pharmaceutica","startDate":"2025-08-26","conditions":"Invasive Mold Infections","enrollment":219},{"nctId":"NCT06466135","phase":"PHASE2","title":"Study of WAL0921 in Patients With Glomerular Kidney Diseases","status":"RECRUITING","sponsor":"Walden Biosciences","startDate":"2024-07-02","conditions":"Diabetic Nephropathies, Primary Focal Segmental Glomerulosclerosis, Minimal Change Disease","enrollment":96},{"nctId":"NCT07463430","phase":"PHASE4","title":"Suzetrigine for Non-Mastectomy Breast Surgery","status":"NOT_YET_RECRUITING","sponsor":"University of California, San Diego","startDate":"2026-03-30","conditions":"Pain, Acute Postoperative, Breast Disease","enrollment":120},{"nctId":"NCT07250269","phase":"PHASE1","title":"Study of GC012F, CAR-T Therapy Targeting CD19 and BCMA in Chinese Participants With Relapsed or Refractory AL Amyloidosis","status":"RECRUITING","sponsor":"Gracell Biotechnologies (Shanghai) Co., Ltd.","startDate":"2025-10-29","conditions":"Relapsed/Refractory AL Amyloidosis","enrollment":9},{"nctId":"NCT06425159","phase":"PHASE2, PHASE3","title":"A Study to Determine if BHV-7000 is Effective and Safe in Adults With Idiopathic Generalized Epilepsy With Generalized Tonic-clonic Seizures","status":"TERMINATED","sponsor":"Biohaven Therapeutics Ltd.","startDate":"2024-06-20","conditions":"Generalized Epilepsy","enrollment":27},{"nctId":"NCT07490743","phase":"NA","title":"Eye-Ear Sleep Band for Sleep Quality in Coronary Care Unit","status":"COMPLETED","sponsor":"Koç University","startDate":"2019-05-01","conditions":"Acute Coronary Syndromes (ACS), Sleep Quality, Sleep Deprivation","enrollment":100},{"nctId":"NCT05548296","phase":"PHASE2","title":"A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma","status":"RECRUITING","sponsor":"Acrivon Therapeutics","startDate":"2022-08-29","conditions":"Endometrial Adenocarcinoma","enrollment":353},{"nctId":"NCT06325709","phase":"PHASE1, PHASE2","title":"Base Editing for Mutation Repair in Hematopoietic Stem & Progenitor Cells for X-Linked Chronic Granulomatous Disease","status":"RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2024-04-17","conditions":"Chronic Granulomatous Disease (CGD), X-Linked Chronic Granulomatous Disease","enrollment":10},{"nctId":"NCT07491107","phase":"","title":"Brazilian Prospective Registry of the Inspiron EVO Drug-Eluting Stent in Complex Coronary Lesions","status":"NOT_YET_RECRUITING","sponsor":"Scitech Produtos Medicos SA","startDate":"2026-04-30","conditions":"Coronary Artery Disease (CAD), Stenosis Coronary, Small Vessel Ischemic Disease","enrollment":2000},{"nctId":"NCT06462794","phase":"PHASE1","title":"First In Human Study of CX-801 in Advanced Solid Tumors","status":"RECRUITING","sponsor":"CytomX Therapeutics","startDate":"2024-08-28","conditions":"Solid Tumor, Adult","enrollment":121},{"nctId":"NCT02758951","phase":"PHASE2, PHASE3","title":"Perioperative Systemic Therapy for Isolated Resectable Colorectal Peritoneal Metastases","status":"ACTIVE_NOT_RECRUITING","sponsor":"Koen Rovers","startDate":"2017-06-01","conditions":"Colorectal Neoplasm, Colorectal Cancer, Colorectal Neoplasms Malignant","enrollment":358},{"nctId":"NCT04930237","phase":"","title":"RELISTOR's Effects on Opioid-Induced Constipation","status":"WITHDRAWN","sponsor":"Methodist Health System","startDate":"2021-07-01","conditions":"OIC","enrollment":""},{"nctId":"NCT07190690","phase":"NA","title":"Comparison of a Contemporary Sirolimus-eluting Stent (ihtDEStiny®) With Another Everolimus-eluting Stent (Xience™), Both With Permanent Polymers, in Patients With Acute Coronary Syndrome and de Novo Coronary Artery Lesions","status":"RECRUITING","sponsor":"Fundación EPIC","startDate":"2025-12-19","conditions":"Coronary Artery Disease","enrollment":2100},{"nctId":"NCT06821542","phase":"PHASE3","title":"A Study to Evaluate Axatilimab Versus Best Available Therapy in Participants With Chronic Graft Versus Host Disease After at Least 2 Prior Lines of Systemic Therapy","status":"ACTIVE_NOT_RECRUITING","sponsor":"Incyte Corporation","startDate":"2025-06-04","conditions":"Chronic Graft-versus-host-disease","enrollment":9},{"nctId":"NCT06780085","phase":"PHASE2","title":"A Study of Investigational Agents in Participants With Previously Treated Stage IV Nonsquamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01H/KEYMAKER-U01)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2025-05-13","conditions":"Carcinoma, Non-Small-Cell Lung","enrollment":96},{"nctId":"NCT05467891","phase":"PHASE2","title":"Ribociclib And Endocrine Treatment of Physician's Choice for Locoregional Recurrent, Resected Hormone Receptor Positive HER2 Negative Breast Cancer","status":"RECRUITING","sponsor":"Oana Danciu","startDate":"2022-09-13","conditions":"Locoregional Recurrence, Hormone Receptor-positive Breast Cancer, HER2-negative Breast Cancer","enrollment":200},{"nctId":"NCT07462663","phase":"","title":"SHAPE-ENDO: Multimodal Pre-Surgical Optimization in Patients With Obesity and Early-Stage Endometrial Cancer","status":"NOT_YET_RECRUITING","sponsor":"Hospital Universitari de Bellvitge","startDate":"2026-05","conditions":"Endometrial Cancer, Endometrial Cancer Stage I, Atypical Endometrial Hyperplasia and Endometrial Carcinoma Stage I","enrollment":82},{"nctId":"NCT06309966","phase":"PHASE2, PHASE3","title":"Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy","status":"RECRUITING","sponsor":"Biohaven Therapeutics Ltd.","startDate":"2024-05-13","conditions":"Focal Epilepsy","enrollment":390},{"nctId":"NCT06667141","phase":"PHASE1","title":"Phase 1 Study of ACR-2316 in Specific Advanced Solid Tumors","status":"RECRUITING","sponsor":"Acrivon Therapeutics","startDate":"2024-10-08","conditions":"Specific Advanced Solid Tumors","enrollment":100},{"nctId":"NCT06692959","phase":"PHASE2","title":"A Phase II Trial of Neoadjuvant PD-1 Vaccine PD1-Vaxx in Operable MSI High Colorectal Cancer","status":"RECRUITING","sponsor":"University of Southampton","startDate":"2025-06-16","conditions":"Colorectal Cancer","enrollment":44},{"nctId":"NCT06793397","phase":"PHASE3","title":"A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder","status":"RECRUITING","sponsor":"Cybin IRL Limited","startDate":"2025-12-10","conditions":"Major Depressive Disorder (MDD), Depression in Adults, Depression - Major Depressive Disorder","enrollment":330},{"nctId":"NCT06788990","phase":"PHASE2, PHASE3","title":"FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC","status":"RECRUITING","sponsor":"Bicara Therapeutics","startDate":"2025-01-28","conditions":"Metastatic Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma","enrollment":650},{"nctId":"NCT07487441","phase":"","title":"Reverse Remodeling of the Pulmonary Vasculature: a Longitudinal, Investigational Study of the Effects of Sotatercept.","status":"NOT_YET_RECRUITING","sponsor":"Franz Rischard, DO","startDate":"2026-03-15","conditions":"Pulmonary Arterial Hypertension (PAH), Pulmonary Hypertension","enrollment":30},{"nctId":"NCT07417124","phase":"PHASE1","title":"Assess the Safety and Tolerability of SNS851 in Healthy Participants","status":"RECRUITING","sponsor":"Oneness Biotech Co., Ltd.","startDate":"2026-03","conditions":"Metabolic Disease","enrollment":52},{"nctId":"NCT02840175","phase":"PHASE3","title":"Treatment Tapering in JIA With Inactive Disease","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2017-05-18","conditions":"Juvenile Idiopathic Arthritis","enrollment":62},{"nctId":"NCT07488234","phase":"NA","title":"Impact of a Glaucoma Awareness Program on Treatment Adherence","status":"NOT_YET_RECRUITING","sponsor":"Seva Canada Society","startDate":"2026-04","conditions":"Glaucoma","enrollment":60},{"nctId":"NCT06132893","phase":"PHASE2, PHASE3","title":"A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy","status":"RECRUITING","sponsor":"Biohaven Therapeutics Ltd.","startDate":"2024-03-14","conditions":"Focal Epilepsy","enrollment":390},{"nctId":"NCT06293898","phase":"PHASE1","title":"Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors","status":"RECRUITING","sponsor":"SystImmune Inc.","startDate":"2024-02-09","conditions":"Endometrial Cancer, Cervical Cancer, Ovarian Cancer","enrollment":280},{"nctId":"NCT06827236","phase":"PHASE1, PHASE2","title":"A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer","status":"RECRUITING","sponsor":"BioNTech SE","startDate":"2025-04-23","conditions":"Locally Advanced Breast Cancer, Unresectable Breast Carcinoma, Metastatic Breast Cancer","enrollment":380},{"nctId":"NCT05319730","phase":"PHASE1, PHASE2","title":"A Study to Evaluate Investigational Agents With or Without Pembrolizumab (MK-3475) in Participants With Advanced Esophageal Cancer Previously Exposed to Programmed Cell Death 1 Protein (PD-1)/ Programmed Cell Death Ligand 1 (PD-L1) Treatment (MK-3475-06B)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2023-05-16","conditions":"Esophageal Squamous Cell Carcinoma","enrollment":230},{"nctId":"NCT05761080","phase":"PHASE4","title":"Fast Track Therapeutic Model in Acute Complicated Appendicitis in Pediatrics","status":"RECRUITING","sponsor":"Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau","startDate":"2021-04-22","conditions":"Laparoscopic Appendectomy, Complicated Appendicitis, Periappendicular Abscess","enrollment":772},{"nctId":"NCT02016924","phase":"PHASE2, PHASE3","title":"Study of Cobicistat-Boosted Atazanavir (ATV/co), Cobicistat-Boosted Darunavir (DRV/co) and Emtricitabine/Tenofovir Alafenamide (F/TAF) in Children With HIV","status":"ACTIVE_NOT_RECRUITING","sponsor":"Gilead Sciences","startDate":"2014-01-16","conditions":"Acquired Immune Deficiency Syndrome (AIDS), HIV Infections","enrollment":133},{"nctId":"NCT04222413","phase":"PHASE1","title":"Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2020-10-27","conditions":"Advanced Solid Tumors, Metastatic Pancreatic Cancer, Pediatric Solid Tumor","enrollment":116},{"nctId":"NCT06248073","phase":"NA","title":"Effectiveness of Online Program and Task-related Training for Parkinson's Disease","status":"RECRUITING","sponsor":"Chang Gung University","startDate":"2024-03-01","conditions":"Parkinson Disease, Occupational Therapy, Telerehabilitation","enrollment":100},{"nctId":"NCT07232602","phase":"PHASE1, PHASE2","title":"KEYMAKER-U04 Substudy 04D: A Clinical Study of New Treatments Given With Enfortumab Vedotin and Pembrolizumab in People With Urothelial Cancer (MK-3475-04D/KEYMAKER-U04)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2026-02-09","conditions":"Bladder Cancer","enrollment":55},{"nctId":"NCT07484750","phase":"NA","title":"Efficacy and Influencing Factors of Mindfulness-Based Exposure Group Therapy for OCD","status":"RECRUITING","sponsor":"Shanghai Mental Health Center","startDate":"2026-02-03","conditions":"Obessive-Compulsive Disorder","enrollment":64},{"nctId":"NCT07124078","phase":"PHASE2","title":"A Study to Evaluate Axatilimab Versus Best Available Therapy in Pediatric Participants With Chronic Graft-Versus-Host Disease After at Least 2 Prior Lines of Systemic Therapy (AGAVE-256)","status":"RECRUITING","sponsor":"Incyte Corporation","startDate":"2026-03-31","conditions":"Chronic Graft-versus-host-disease","enrollment":60},{"nctId":"NCT05953948","phase":"NA","title":"Effectiveness of Intelligent Case Manage Platform in Liver Transplant Recipients","status":"ENROLLING_BY_INVITATION","sponsor":"Chang Gung University","startDate":"2025-02-01","conditions":"Liver Transplant Disorder, Self Efficacy, Quality of Life","enrollment":333},{"nctId":"NCT06592508","phase":"NA","title":"Evaluation Of A Virtual Cardiology Program To Improve Outcomes After Acute Decompensated Heart Failure","status":"ACTIVE_NOT_RECRUITING","sponsor":"Duke University","startDate":"2024-09-27","conditions":"Heart Failure; With Decompensation","enrollment":180}],"_emaApprovals":[],"_faersSignals":[{"count":99,"reaction":"FEBRILE NEUTROPENIA"},{"count":80,"reaction":"NAUSEA"},{"count":71,"reaction":"PYREXIA"},{"count":70,"reaction":"ANAEMIA"},{"count":67,"reaction":"DEHYDRATION"},{"count":61,"reaction":"FATIGUE"},{"count":61,"reaction":"VOMITING"},{"count":59,"reaction":"DYSPNOEA"},{"count":53,"reaction":"DIARRHOEA"},{"count":52,"reaction":"NEUTROPENIA"}],"_approvalHistory":[],"publicationCount":1199,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["IFALMIN (standardized extract from channa micropeltes)"],"phase":"phase_3","status":"active","brandName":"Investigational drug","genericName":"Investigational drug","companyName":"Pfizer","companyId":"pfizer","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}